nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Sparfloxacin—ABCB1—peripheral nervous system neoplasm	0.00213	0.42	CrCbGaD
Gemifloxacin—Levofloxacin—ABCB1—peripheral nervous system neoplasm	0.0015	0.295	CrCbGaD
Gemifloxacin—Ciprofloxacin—ABCB1—peripheral nervous system neoplasm	0.00145	0.285	CrCbGaD
Gemifloxacin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000762	0.000766	CcSEcCtD
Gemifloxacin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00076	0.000764	CcSEcCtD
Gemifloxacin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000759	0.000763	CcSEcCtD
Gemifloxacin—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000759	0.000763	CcSEcCtD
Gemifloxacin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000758	0.000762	CcSEcCtD
Gemifloxacin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000758	0.000762	CcSEcCtD
Gemifloxacin—Pain—Vincristine—peripheral nervous system neoplasm	0.000756	0.00076	CcSEcCtD
Gemifloxacin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000756	0.00076	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000756	0.00076	CcSEcCtD
Gemifloxacin—Rash—Melphalan—peripheral nervous system neoplasm	0.000753	0.000757	CcSEcCtD
Gemifloxacin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000753	0.000757	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00075	0.000754	CcSEcCtD
Gemifloxacin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000745	0.000749	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000742	0.000746	CcSEcCtD
Gemifloxacin—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000738	0.000742	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000735	0.000739	CcSEcCtD
Gemifloxacin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.00073	0.000733	CcSEcCtD
Gemifloxacin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000729	0.000733	CcSEcCtD
Gemifloxacin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000725	0.000729	CcSEcCtD
Gemifloxacin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000725	0.000729	CcSEcCtD
Gemifloxacin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000725	0.000729	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000723	0.000727	CcSEcCtD
Gemifloxacin—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000723	0.000727	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00072	0.000724	CcSEcCtD
Gemifloxacin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000719	0.000723	CcSEcCtD
Gemifloxacin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000719	0.000723	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000716	0.00072	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000712	0.000716	CcSEcCtD
Gemifloxacin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00071	0.000714	CcSEcCtD
Gemifloxacin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00071	0.000713	CcSEcCtD
Gemifloxacin—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.000712	CcSEcCtD
Gemifloxacin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000706	0.00071	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000701	0.000705	CcSEcCtD
Gemifloxacin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000699	0.000703	CcSEcCtD
Gemifloxacin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000699	0.000703	CcSEcCtD
Gemifloxacin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000699	0.000702	CcSEcCtD
Gemifloxacin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000699	0.000702	CcSEcCtD
Gemifloxacin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000697	0.0007	CcSEcCtD
Gemifloxacin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000696	0.000699	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000692	0.000696	CcSEcCtD
Gemifloxacin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000692	0.000696	CcSEcCtD
Gemifloxacin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000683	0.000686	CcSEcCtD
Gemifloxacin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000683	0.000686	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000681	0.000684	CcSEcCtD
Gemifloxacin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00068	0.000683	CcSEcCtD
Gemifloxacin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000677	0.00068	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000675	0.000678	CcSEcCtD
Gemifloxacin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000669	0.000672	CcSEcCtD
Gemifloxacin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000668	0.000672	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.00067	CcSEcCtD
Gemifloxacin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000658	0.000662	CcSEcCtD
Gemifloxacin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000653	0.000657	CcSEcCtD
Gemifloxacin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000649	0.000652	CcSEcCtD
Gemifloxacin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000647	0.00065	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000644	0.000648	CcSEcCtD
Gemifloxacin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00064	0.000644	CcSEcCtD
Gemifloxacin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000638	0.000642	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000637	0.00064	CcSEcCtD
Gemifloxacin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000637	0.00064	CcSEcCtD
Gemifloxacin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000634	0.000638	CcSEcCtD
Gemifloxacin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000633	0.000636	CcSEcCtD
Gemifloxacin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000629	0.000633	CcSEcCtD
Gemifloxacin—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000629	0.000633	CcSEcCtD
Gemifloxacin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000629	0.000632	CcSEcCtD
Gemifloxacin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000628	0.000631	CcSEcCtD
Gemifloxacin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000624	0.000627	CcSEcCtD
Gemifloxacin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000623	0.000626	CcSEcCtD
Gemifloxacin—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000619	0.000622	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000618	0.000621	CcSEcCtD
Gemifloxacin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000618	0.000621	CcSEcCtD
Gemifloxacin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000617	0.000621	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000617	0.00062	CcSEcCtD
Gemifloxacin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000614	0.000617	CcSEcCtD
Gemifloxacin—Pain—Etoposide—peripheral nervous system neoplasm	0.000612	0.000616	CcSEcCtD
Gemifloxacin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000612	0.000616	CcSEcCtD
Gemifloxacin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000607	0.00061	CcSEcCtD
Gemifloxacin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000605	0.000608	CcSEcCtD
Gemifloxacin—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.0006	0.000603	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000596	0.000599	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000598	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000589	0.000592	CcSEcCtD
Gemifloxacin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000588	0.000591	CcSEcCtD
Gemifloxacin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000587	0.00059	CcSEcCtD
Gemifloxacin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000586	0.000589	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000586	0.000589	CcSEcCtD
Gemifloxacin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000585	0.000588	CcSEcCtD
Gemifloxacin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000583	0.000586	CcSEcCtD
Gemifloxacin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.000585	CcSEcCtD
Gemifloxacin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.000585	CcSEcCtD
Gemifloxacin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.000581	CcSEcCtD
Gemifloxacin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.000581	CcSEcCtD
Gemifloxacin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000575	0.000578	CcSEcCtD
Gemifloxacin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000572	0.000575	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.000574	CcSEcCtD
Gemifloxacin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000569	0.000572	CcSEcCtD
Gemifloxacin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000568	0.000571	CcSEcCtD
Gemifloxacin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000568	0.000571	CcSEcCtD
Gemifloxacin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000566	0.000569	CcSEcCtD
Gemifloxacin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000566	0.000569	CcSEcCtD
Gemifloxacin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000565	0.000568	CcSEcCtD
Gemifloxacin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000562	0.000565	CcSEcCtD
Gemifloxacin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000561	0.000564	CcSEcCtD
Gemifloxacin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000561	0.000564	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000558	0.000561	CcSEcCtD
Gemifloxacin—Rash—Vincristine—peripheral nervous system neoplasm	0.000557	0.00056	CcSEcCtD
Gemifloxacin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000557	0.00056	CcSEcCtD
Gemifloxacin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000557	0.000559	CcSEcCtD
Gemifloxacin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.000558	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000555	0.000558	CcSEcCtD
Gemifloxacin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000557	CcSEcCtD
Gemifloxacin—Headache—Vincristine—peripheral nervous system neoplasm	0.000554	0.000557	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.000554	CcSEcCtD
Gemifloxacin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000545	0.000548	CcSEcCtD
Gemifloxacin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000545	0.000547	CcSEcCtD
Gemifloxacin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.000546	CcSEcCtD
Gemifloxacin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000535	0.000538	CcSEcCtD
Gemifloxacin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000534	0.000537	CcSEcCtD
Gemifloxacin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000528	0.000531	CcSEcCtD
Gemifloxacin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000528	CcSEcCtD
Gemifloxacin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000525	0.000528	CcSEcCtD
Gemifloxacin—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000527	CcSEcCtD
Gemifloxacin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000527	CcSEcCtD
Gemifloxacin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000523	0.000525	CcSEcCtD
Gemifloxacin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000519	0.000522	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000516	0.000519	CcSEcCtD
Gemifloxacin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.000518	CcSEcCtD
Gemifloxacin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000514	0.000516	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.000516	CcSEcCtD
Gemifloxacin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000513	0.000515	CcSEcCtD
Gemifloxacin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.000515	CcSEcCtD
Gemifloxacin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00051	0.000513	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000509	0.000512	CcSEcCtD
Gemifloxacin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000507	0.000509	CcSEcCtD
Gemifloxacin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000504	0.000506	CcSEcCtD
Gemifloxacin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000497	0.0005	CcSEcCtD
Gemifloxacin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000495	0.000498	CcSEcCtD
Gemifloxacin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.000497	CcSEcCtD
Gemifloxacin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000493	0.000495	CcSEcCtD
Gemifloxacin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000492	0.000495	CcSEcCtD
Gemifloxacin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00049	0.000493	CcSEcCtD
Gemifloxacin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.000491	CcSEcCtD
Gemifloxacin—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000488	CcSEcCtD
Gemifloxacin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000488	CcSEcCtD
Gemifloxacin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000487	CcSEcCtD
Gemifloxacin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000483	0.000485	CcSEcCtD
Gemifloxacin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000482	0.000484	CcSEcCtD
Gemifloxacin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000478	0.00048	CcSEcCtD
Gemifloxacin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000476	0.000478	CcSEcCtD
Gemifloxacin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000474	0.000477	CcSEcCtD
Gemifloxacin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000474	0.000476	CcSEcCtD
Gemifloxacin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000473	0.000475	CcSEcCtD
Gemifloxacin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.000475	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.000474	CcSEcCtD
Gemifloxacin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000464	0.000467	CcSEcCtD
Gemifloxacin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.00046	CcSEcCtD
Gemifloxacin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000455	0.000458	CcSEcCtD
Gemifloxacin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000457	CcSEcCtD
Gemifloxacin—Rash—Etoposide—peripheral nervous system neoplasm	0.000452	0.000454	CcSEcCtD
Gemifloxacin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000451	0.000453	CcSEcCtD
Gemifloxacin—Headache—Etoposide—peripheral nervous system neoplasm	0.000449	0.000451	CcSEcCtD
Gemifloxacin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000448	0.000451	CcSEcCtD
Gemifloxacin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.000449	CcSEcCtD
Gemifloxacin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.000448	CcSEcCtD
Gemifloxacin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000444	CcSEcCtD
Gemifloxacin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000444	CcSEcCtD
Gemifloxacin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000441	0.000443	CcSEcCtD
Gemifloxacin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00044	0.000443	CcSEcCtD
Gemifloxacin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000442	CcSEcCtD
Gemifloxacin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.00044	CcSEcCtD
Gemifloxacin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000435	0.000437	CcSEcCtD
Gemifloxacin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000435	CcSEcCtD
Gemifloxacin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000425	0.000428	CcSEcCtD
Gemifloxacin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000423	CcSEcCtD
Gemifloxacin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000421	CcSEcCtD
Gemifloxacin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000421	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000418	CcSEcCtD
Gemifloxacin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00041	0.000412	CcSEcCtD
Gemifloxacin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000411	CcSEcCtD
Gemifloxacin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.00041	CcSEcCtD
Gemifloxacin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000409	CcSEcCtD
Gemifloxacin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.000404	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000403	CcSEcCtD
Gemifloxacin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000403	CcSEcCtD
Gemifloxacin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.000402	CcSEcCtD
Gemifloxacin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000395	0.000397	CcSEcCtD
Gemifloxacin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000396	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000395	CcSEcCtD
Gemifloxacin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000394	CcSEcCtD
Gemifloxacin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000392	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000388	0.00039	CcSEcCtD
Gemifloxacin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000389	CcSEcCtD
Gemifloxacin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000389	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000387	CcSEcCtD
Gemifloxacin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000385	CcSEcCtD
Gemifloxacin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.000381	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000373	CcSEcCtD
Gemifloxacin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000373	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000368	CcSEcCtD
Gemifloxacin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000367	CcSEcCtD
Gemifloxacin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000366	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000366	CcSEcCtD
Gemifloxacin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000365	CcSEcCtD
Gemifloxacin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000364	CcSEcCtD
Gemifloxacin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000363	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000361	CcSEcCtD
Gemifloxacin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000358	0.00036	CcSEcCtD
Gemifloxacin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000359	CcSEcCtD
Gemifloxacin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000356	CcSEcCtD
Gemifloxacin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000355	CcSEcCtD
Gemifloxacin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000351	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000348	CcSEcCtD
Gemifloxacin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000348	CcSEcCtD
Gemifloxacin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000345	CcSEcCtD
Gemifloxacin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000345	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.00034	CcSEcCtD
Gemifloxacin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000338	CcSEcCtD
Gemifloxacin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000333	CcSEcCtD
Gemifloxacin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000332	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000328	0.00033	CcSEcCtD
Gemifloxacin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000329	CcSEcCtD
Gemifloxacin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000325	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000322	CcSEcCtD
Gemifloxacin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000322	CcSEcCtD
Gemifloxacin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000321	CcSEcCtD
Gemifloxacin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000319	CcSEcCtD
Gemifloxacin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000319	CcSEcCtD
Gemifloxacin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000319	CcSEcCtD
Gemifloxacin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000319	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000305	CcSEcCtD
Gemifloxacin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000297	CcSEcCtD
Gemifloxacin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000295	CcSEcCtD
Gemifloxacin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000295	CcSEcCtD
Gemifloxacin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000289	CcSEcCtD
Gemifloxacin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000285	CcSEcCtD
Gemifloxacin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000276	CcSEcCtD
Gemifloxacin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000268	CcSEcCtD
Gemifloxacin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000267	CcSEcCtD
Gemifloxacin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000264	CcSEcCtD
Gemifloxacin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000257	CcSEcCtD
Gemifloxacin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000255	CcSEcCtD
Gemifloxacin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000254	CcSEcCtD
Gemifloxacin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000254	CcSEcCtD
Gemifloxacin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000253	CcSEcCtD
Gemifloxacin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000247	CcSEcCtD
Gemifloxacin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000238	0.00024	CcSEcCtD
Gemifloxacin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000237	CcSEcCtD
Gemifloxacin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000235	CcSEcCtD
Gemifloxacin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000235	CcSEcCtD
Gemifloxacin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000234	CcSEcCtD
Gemifloxacin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000222	CcSEcCtD
